NDC 0338-6011 – Milrinone Lactate in Dextrose
Milrinone Lactate .2 mg/mL · Injection, Solution · Intravenous
Product NDC0338-6011
Product details
- Brand name
- Milrinone Lactate in Dextrose
- Generic name
- Milrinone Lactate
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA075834
- Marketed since
- May 28, 2002
- Listing expires
- December 31, 2027
- Pharmacologic class
- Phosphodiesterase 3 Inhibitor
Active ingredients
- Milrinone Lactate .2 mg/mL
Uses, dosage, side effects and warnings for Milrinone Lactate in Dextrose →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0338-6011-37 | 10 BAG in 1 CARTON (0338-6011-37) / 200 mL in 1 BAG | May 28, 2002 |
Recalls mentioning this NDC
- D-0789-2017 May 24, 2017 · Class II
Lack of assurance of sterility: customer complaints received for the presence of leaks.
Other Milrinone Lactate in Dextrose products
- 0338-6010 Milrinone Lactate .2 mg/mL · Injection, Solution · Baxter Healthcare Corporation
- 68083-410 Milrinone Lactate .2 mg/mL · Injection, Solution · Gland Pharma Limited
- 68083-411 Milrinone Lactate .2 mg/mL · Injection, Solution · Gland Pharma Limited
- 0143-9718 Milrinone Lactate 200 ug/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9719 Milrinone Lactate 200 ug/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 0409-1983 Milrinone Lactate .2 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-2045 Milrinone Lactate .2 mg/mL · Injection, Solution · Hospira, Inc.
- 25021-313 Milrinone Lactate .2 mg/mL · Injection, Solution · Sagent Pharmaceuticals